Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDM: Metformin and Lifestyle Intervention in Prediabetic Adult Survivors of Childhood Cancer
NCT04742751Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Mar 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liquid metformin (Aspargo Labs) in prediabetes, sponsored by St. Jude Children's Research Hospital. Primary endpoints: Adherence for feasibility at 2 years, Digitally-delivered core education curriculum completion at Week 24 and 2 more. Started Mar 2022; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT04742751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742751.